Suggestions
James Lanthier
Chief Executive Officer at Mindset Pharma Inc
James Lanthier is the Chief Executive Officer of Mindset Pharma Inc., a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric disorders.1 He is a seasoned technology executive with strong expertise in corporate finance, public markets, and M&A.4
Lanthier has been leading Mindset Pharma's efforts to develop novel families of next-generation psychedelic compounds and innovative processes to chemically synthesize psilocybins.1 Under his leadership, the company has filed multiple patents and patent applications, and has entered into a co-development agreement with the McQuade Center for Strategic Research and Development, a member of the Otsuka Pharmaceuticals family of companies.1
Prior to his role at Mindset Pharma, Lanthier gained experience in various executive positions. He holds an education from the University of Toronto - Rotman School of Management.2 In addition to his role at Mindset Pharma, Lanthier also serves as an Independent Director at Water Ways Technologies, Inc. since 2019.3
On October 27, 2023, Lanthier announced the closing of an arrangement involving Mindset Pharma, indicating a significant development for the company and its shareholders.5
